Aker BioMarine

Aker BioMarine AS
Company typePublic (OSE: AKBM)
IndustryMarine biotechnology
Headquarters,
Key people
Matts Johansen (CEO)
Ola Snøve (chair)
Revenue469 million kr (2012)
NOK –35 million (2012)
NOK –66 million (2012)
Websitewww.akerbiomarine.com

Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM).